May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Optic Nerve Ligation-Induced Interleukin-1 Beta Through MAP Kinase Mediates MMP-9 Induction and Retinal Damage
Author Affiliations & Notes
  • S.K. Chintala
    Eye Research Institute, Oakland University, Rochester, MI, United States
  • X. Zhang
    Eye Research Institute, Oakland University, Rochester, MI, United States
  • Footnotes
    Commercial Relationships  S.K. Chintala, None; X. Zhang, None.
  • Footnotes
    Support  NEI-EY13643
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3329. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.K. Chintala, X. Zhang; Optic Nerve Ligation-Induced Interleukin-1 Beta Through MAP Kinase Mediates MMP-9 Induction and Retinal Damage . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3329.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We previously have shown that optic nerve ligation-induced ganglion cell loss was associated with matrix metalloproteinase-9 (MMP-9) induction in the retina. The objective of the present study was to determine whether optic nerve ligation-induced interleukin-1 beta (IL-1ß) through mitogen activated protein (MAP) kinases cause induction of MMP-9 and subsequent retinal damage. Methods: Retinal ganglion cell loss in CD-1 mice was induced by optic nerve ligation. Retinal proteins from control and optic nerve ligated retinas were extracted three hours to 1 week after optic nerve ligation, and IL-1ß levels were determined using an ELISA kit. MAP Kinase activation and MMP-9 synthesis was determined by western blot analysis. Retinal morphology was assessed by Hematoxylin & Eosin staining. Results: Optic nerve ligation led to progressive loss of ganglion cells in the retina. Compared to controls, IL-1ß levels were increased as early as 12h, reached a peak by day 2, and returned to undetectable levels by day 6. Peak IL-1ß levels observed 2 days after optic nerve ligation were associated with induction of phosphorylated p44/42 MAPK/extracellular signal-regulated kinase (Erk1 and Erk2) and MMP-9 synthesis. Compared to controls, no change in p38 MAP kinase and c-jun N-terminal kinase was observed after optic nerve ligation. Intravitreal injection of IL-1 receptor antagonist (10 ng) or U0126 (200 nM), a MAP kinase kinase (MEK) inhibitor 10 min before optic nerve ligation resulted in reduced Erk1 and Erk2 activation 2 days after optic nerve ligation. Finally, optic nerve ligation-induced peak expression of MMP-9 synthesis at day 2 was reduced by intravitreal injection of IL-1 receptor antagonist, followed by reduced retinal ganglion cell loss by 1 week. Conclusions: These results suggest that optic nerve ligation-induced IL-1ß through MEK and its down stream target ERK1/2 kinase mediates MMP-9 induction in the retina and plays an important role in retinal damage.

Keywords: ischemia • retina • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×